{"entity":{"type":"insider","cik":"0001385155","url":"/insider/0001385155","json_url":"/insider/0001385155.json","name":"Meeker David P","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":14,"n_filings":13,"first":"2008-08-18","last":"2025-06-05","span_basis":"filed_date"},"name_variants":[{"name":"Meeker David P","source":"filing","n_filings":13,"first_seen":"2008-08-18","last_seen":"2025-06-05"}],"transactions":[{"id":4168251,"accession":"0001104659-25-056838","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001104659-25-056838","line_url":"/filing/0001104659-25-056838#line-3","is_derivative":false,"issuer_cik":"0001385155","issuer_name":"RHYTHM PHARMACEUTICALS, INC.","issuer_ticker":"RYTM","issuer_name_source":null,"issuer_url":"/issuer/0001385155","owner_cik":"0001385155","owner_name":"Meeker David P","owner_display_name":"Meeker David P","owner_url":"/insider/0001385155","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":43346.0,"shares_display":"43,346","price_per_share":65.0431,"price_display":"65.04","price_state":"stated","total_value":2819358.2126,"total_display":"2,819,358.21","total_whole":"2,819,358","shares_owned_after":202099.0,"shares_owned_after_display":"202,099","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-06-03","filed_date":"2025-06-05","scope":"insider"},{"id":4168245,"accession":"0001104659-25-056838","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-25-056838","line_url":"/filing/0001104659-25-056838#line-2","is_derivative":false,"issuer_cik":"0001385155","issuer_name":"RHYTHM PHARMACEUTICALS, INC.","issuer_ticker":"RYTM","issuer_name_source":null,"issuer_url":"/issuer/0001385155","owner_cik":"0001385155","owner_name":"Meeker David P","owner_display_name":"Meeker David P","owner_url":"/insider/0001385155","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":274.0,"shares_display":"274","price_per_share":65.6027,"price_display":"65.60","price_state":"stated","total_value":17975.1398,"total_display":"17,975.14","total_whole":"17,975","shares_owned_after":201825.0,"shares_owned_after_display":"201,825","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-06-03","filed_date":"2025-06-05","scope":"insider"},{"id":4198530,"accession":"0001104659-25-015322","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-25-015322","line_url":"/filing/0001104659-25-015322#line-2","is_derivative":false,"issuer_cik":"0001385155","issuer_name":"RHYTHM PHARMACEUTICALS, INC.","issuer_ticker":"RYTM","issuer_name_source":null,"issuer_url":"/issuer/0001385155","owner_cik":"0001385155","owner_name":"Meeker David P","owner_display_name":"Meeker David P","owner_url":"/insider/0001385155","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9896.0,"shares_display":"9,896","price_per_share":57.22,"price_display":"57.22","price_state":"stated","total_value":566249.12,"total_display":"566,249.12","total_whole":"566,249","shares_owned_after":201281.0,"shares_owned_after_display":"201,281","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-02-19","filed_date":"2025-02-19","scope":"insider"},{"id":4198431,"accession":"0001104659-25-009285","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-25-009285","line_url":"/filing/0001104659-25-009285#line-2","is_derivative":false,"issuer_cik":"0001385155","issuer_name":"RHYTHM PHARMACEUTICALS, INC.","issuer_ticker":"RYTM","issuer_name_source":null,"issuer_url":"/issuer/0001385155","owner_cik":"0001385155","owner_name":"Meeker David P","owner_display_name":"Meeker David P","owner_url":"/insider/0001385155","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4278.0,"shares_display":"4,278","price_per_share":59.43,"price_display":"59.43","price_state":"stated","total_value":254241.54,"total_display":"254,241.54","total_whole":"254,242","shares_owned_after":189927.0,"shares_owned_after_display":"189,927","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-02-04","filed_date":"2025-02-04","scope":"insider"},{"id":2277183,"accession":"0000950170-24-101926","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-24-101926","line_url":"/filing/0000950170-24-101926#line-2","is_derivative":false,"issuer_cik":"0001385155","issuer_name":"Trevi Therapeutics, Inc.","issuer_ticker":"TRVI","issuer_name_source":null,"issuer_url":"/issuer/0001385155","owner_cik":"0001385155","owner_name":"Meeker David P","owner_display_name":"Meeker David P","owner_url":"/insider/0001385155","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4555.0,"shares_display":"4,555","price_per_share":2.9314,"price_display":"2.93","price_state":"stated","total_value":13352.527,"total_display":"13,352.53","total_whole":"13,353","shares_owned_after":352489.0,"shares_owned_after_display":"352,489","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-08-27","filed_date":"2024-08-29","scope":"insider"},{"id":2656609,"accession":"0001104659-24-036316","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-24-036316","line_url":"/filing/0001104659-24-036316#line-1","is_derivative":false,"issuer_cik":"0001385155","issuer_name":"RHYTHM PHARMACEUTICALS, INC.","issuer_ticker":"RYTM","issuer_name_source":null,"issuer_url":"/issuer/0001385155","owner_cik":"0001385155","owner_name":"Meeker David P","owner_display_name":"Meeker David P","owner_url":"/insider/0001385155","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":45494.0,"shares_display":"45,494","price_per_share":39.22,"price_display":"39.22","price_state":"stated","total_value":1784274.68,"total_display":"1,784,274.68","total_whole":"1,784,275","shares_owned_after":174605.0,"shares_owned_after_display":"174,605","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-03-19","filed_date":"2024-03-19","scope":"insider"},{"id":2656255,"accession":"0001104659-24-010797","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-24-010797","line_url":"/filing/0001104659-24-010797#line-2","is_derivative":false,"issuer_cik":"0001385155","issuer_name":"RHYTHM PHARMACEUTICALS, INC.","issuer_ticker":"RYTM","issuer_name_source":null,"issuer_url":"/issuer/0001385155","owner_cik":"0001385155","owner_name":"Meeker David P","owner_display_name":"Meeker David P","owner_url":"/insider/0001385155","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4361.0,"shares_display":"4,361","price_per_share":45.06,"price_display":"45.06","price_state":"stated","total_value":196506.66,"total_display":"196,506.66","total_whole":"196,507","shares_owned_after":121099.0,"shares_owned_after_display":"121,099","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-02-01","filed_date":"2024-02-05","scope":"insider"},{"id":5501843,"accession":"0001104659-21-044745","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-21-044745","line_url":"/filing/0001104659-21-044745#line-1","is_derivative":false,"issuer_cik":"0001385155","issuer_name":"RHYTHM PHARMACEUTICALS, INC.","issuer_ticker":"RYTM","issuer_name_source":null,"issuer_url":"/issuer/0001385155","owner_cik":"0001385155","owner_name":"Meeker David P","owner_display_name":"Meeker David P","owner_url":"/insider/0001385155","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":20.1713,"price_display":"20.17","price_state":"stated","total_value":201713.0,"total_display":"201,713.00","total_whole":"201,713","shares_owned_after":111335.0,"shares_owned_after_display":"111,335","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-03-30","filed_date":"2021-03-31","scope":"insider"},{"id":8340293,"accession":"0000899243-19-013262","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000899243-19-013262","line_url":"/filing/0000899243-19-013262#line-4","is_derivative":false,"issuer_cik":"0001385155","issuer_name":"Trevi Therapeutics, Inc.","issuer_ticker":"TRVI","issuer_name_source":null,"issuer_url":"/issuer/0001385155","owner_cik":"0001385155","owner_name":"Meeker David P","owner_display_name":"Meeker David P","owner_url":"/insider/0001385155","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":11250.0,"shares_display":"11,250","price_per_share":10.0,"price_display":"10.00","price_state":"stated","total_value":112500.0,"total_display":"112,500.00","total_whole":"112,500","shares_owned_after":352489.0,"shares_owned_after_display":"352,489","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-05-09","filed_date":"2019-05-13","scope":"insider"},{"id":4302916,"accession":"0001104659-17-061577","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-17-061577","line_url":"/filing/0001104659-17-061577#line-2","is_derivative":false,"issuer_cik":"0001385155","issuer_name":"RHYTHM PHARMACEUTICALS, INC.","issuer_ticker":"RYTM","issuer_name_source":null,"issuer_url":"/issuer/0001385155","owner_cik":"0001385155","owner_name":"Meeker David P","owner_display_name":"Meeker David P","owner_url":"/insider/0001385155","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":25000.0,"shares_display":"25,000","price_per_share":17.0,"price_display":"17.00","price_state":"stated","total_value":425000.0,"total_display":"425,000.00","total_whole":"425,000","shares_owned_after":101335.0,"shares_owned_after_display":"101,335","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-10-10","filed_date":"2017-10-10","scope":"insider"},{"id":7224030,"accession":"0001225208-10-014004","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001225208-10-014004","line_url":"/filing/0001225208-10-014004#line-2","is_derivative":false,"issuer_cik":"0000732485","issuer_name":"GENZYME CORP","issuer_ticker":"GENZ","issuer_name_source":null,"issuer_url":"/issuer/0000732485","owner_cik":"0001385155","owner_name":"Meeker David P","owner_display_name":"Meeker David P","owner_url":"/insider/0001385155","role":"Officer (ExecVP,Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (ExecVP,Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"ExecVP,Chief Operating Officer","security_title":"Genzyme common stock (GENZ)","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2732.0,"shares_display":"2,732","price_per_share":45.6,"price_display":"45.60","price_state":"stated","total_value":124579.2,"total_display":"124,579.20","total_whole":"124,579","shares_owned_after":10045.0,"shares_owned_after_display":"10,045","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-05-25","filed_date":"2010-05-26","scope":"insider"},{"id":7514910,"accession":"0001225208-10-013909","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001225208-10-013909","line_url":"/filing/0001225208-10-013909#line-2","is_derivative":false,"issuer_cik":"0000732485","issuer_name":"GENZYME CORP","issuer_ticker":"GENZ","issuer_name_source":null,"issuer_url":"/issuer/0000732485","owner_cik":"0001385155","owner_name":"Meeker David P","owner_display_name":"Meeker David P","owner_url":"/insider/0001385155","role":"Officer (ExecVP,Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (ExecVP,Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"ExecVP,Chief Operating Officer","security_title":"Genzyme common stock (GENZ)","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":16488.0,"shares_display":"16,488","price_per_share":49.06,"price_display":"49.06","price_state":"stated","total_value":808901.28,"total_display":"808,901.28","total_whole":"808,901","shares_owned_after":4694.0,"shares_owned_after_display":"4,694","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-05-21","filed_date":"2010-05-25","scope":"insider"},{"id":5858850,"accession":"0001225208-09-010662","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001225208-09-010662","line_url":"/filing/0001225208-09-010662#line-1","is_derivative":false,"issuer_cik":"0000732485","issuer_name":"GENZYME CORP","issuer_ticker":"GENZ","issuer_name_source":null,"issuer_url":"/issuer/0000732485","owner_cik":"0001385155","owner_name":"Meeker David P","owner_display_name":"Meeker David P","owner_url":"/insider/0001385155","role":"Officer (ExecVP,Therapeutics,Biosurgery)","role_mark":"O","role_mark_label":"Officer (ExecVP,Therapeutics,Biosurgery)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"ExecVP,Therapeutics,Biosurgery","security_title":"Genzyme common stock (GENZ)","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2000.0,"shares_display":"2,000","price_per_share":51.9532,"price_display":"51.95","price_state":"stated","total_value":103906.4,"total_display":"103,906.40","total_whole":"103,906","shares_owned_after":4227.0,"shares_owned_after_display":"4,227","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-04-23","filed_date":"2009-04-24","scope":"insider"},{"id":3392834,"accession":"0000732485-08-000029","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000732485-08-000029","line_url":"/filing/0000732485-08-000029#line-3","is_derivative":false,"issuer_cik":"0000732485","issuer_name":"GENZYME CORP","issuer_ticker":"GENZ","issuer_name_source":null,"issuer_url":"/issuer/0000732485","owner_cik":"0001385155","owner_name":"Meeker David P","owner_display_name":"Meeker David P","owner_url":"/insider/0001385155","role":"Officer (President LSD Therapeutics)","role_mark":"O","role_mark_label":"Officer (President LSD Therapeutics)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President LSD Therapeutics","security_title":"Genzyme common stock (GENZ)","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":17790.0,"shares_display":"17,790","price_per_share":83.19,"price_display":"83.19","price_state":"stated","total_value":1479950.1,"total_display":"1,479,950.10","total_whole":"1,479,950","shares_owned_after":1886.0,"shares_owned_after_display":"1,886","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-08-15","filed_date":"2008-08-18","scope":"insider"}],"next_cursor":null,"ledger_fault":false,"count":{"value":14,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":4,"open_market":true},{"code":"S","label":"Open-market sale","n":10,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":14},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001649904","name":"RHYTHM PHARMACEUTICALS, INC.","url":"/issuer/0001649904","role":"Director, Officer (President and CEO)","n_filings":7,"first_seen":"2017-10-10","last_seen":"2025-06-05"},{"type":"issuer","type_label":"ISSUER","cik":"0001563880","name":"Trevi Therapeutics, Inc.","url":"/issuer/0001563880","role":"Director, Ten percent owner","n_filings":2,"first_seen":"2019-05-13","last_seen":"2024-08-29"},{"type":"issuer","type_label":"ISSUER","cik":"0000732485","name":"GENZYME CORP","url":"/issuer/0000732485","role":"Officer (ExecVP,Chief Operating Officer)","n_filings":4,"first_seen":"2008-08-18","last_seen":"2010-05-26"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001385155","retrieved_at":"2026-08-22T04:56:39+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-20","last_ingest":"2026-08-21T05:23:33.898496+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}